NEXIMMUNE, INC.
Profile
Company Names
NEXIMMUNE, INC.
Addresses
9119 GAITHER ROAD, GAITHERSBURG, MD 20877
22 FIRSTFIELD ROAD, SUITE 280, GAITHERSBURG, MD 20878
Phone Numbers
212-692-6758
301-861-0009
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$34,997,793.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-01-08
$7,767,293.00
$10,000,000.00
$2,232,707.00
Equity
6
2017-12-28
$21,730,000.00
$25,000,000.00
$3,270,000.00
Equity
5
2015-02-03
$1,962,000.00
$1,962,000.00
$0.00
Debt
4
2014-07-10
$3,000,000.00
$3,000,000.00
$0.00
Debt
3
2013-12-23
$250,000.00
$2,000,000.00
$1,750,000.00
Debt
2
2011-11-15
$287,500.00
$287,500.00
$0.00
Equity
1
2011-06-07
$1,000.00
$1,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES
BARRETT
DIRECTOR
PREDICTIVE BIOSCIENCES, INC
| CARDIOXYL PHARMACEUTICALS INC
| PHASEBIO PHARMACEUTICALS INC
| AMICUS THERAPEUTICS INC
| HOMETOWN FINANCIAL GROUP INC
| BLEND BIOSCIENCES, INC.
| BLEND THERAPEUTICS, INC.
| AGENEBIO, INC.
| ZP HOLDINGS INC
| LOXO ONCOLOGY, INC.
| NEXIMMUNE, INC.
| GALERA THERAPEUTICS, INC.
| TARVEDA THERAPEUTICS, INC.
| EDGE TOTAL INTELLIGENCE INC.
| ABSURD SNACKS - LIGHTHOUSE NETWORK VENTURES, LLC
ALAIN
CAPPELUTI
EXECUTIVE OFFICER, DIRECTOR
KENNETH
CARTER
EXECUTIVE OFFICER, DIRECTOR
ROBERT
SPIEGEL
DIRECTOR
FACE2FACE PARTNERS I, LLC
| PRE-IPO OPPORTUNITIES FUND LLC
| EDGE THERAPEUTICS, INC.
| NEXIMMUNE, INC.
| ACUITY OPPORTUNITIES FUND I LLC
| PINES AT WOODCREEK INVESTOR LLC
| ACUITY DATAMINR LLC
| ACUITY DATASTAX LLC
| ACUITY VARO BANK LLC
| ACUITY TANIUM LLC
| ACUITY TURO LLC
| ACUITY EPIRUS LLC
| ACUITY SPV VII LLC
| AYALA PHARMACEUTICALS, INC.
| RENOVORX, INC.
| CYCLACEL PHARMACEUTICALS, INC.
| DAWSON FOREST INVESTORS LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
